ArticleBritish journal of cancer2016

Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer.

Meinolf Karthaus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.